课题基金 / 基金详情

Antifungal susceptibility of new genotype of Candida albicans strains with group 1 intron

Antifungal susceptibility of new genotype of Candida albicans strains with group 1 intron
1组内含子白色念珠菌新基因型菌株的抗真菌敏感性
批准号:
14570231
负责人:
MIKAMI Yuzuru
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

MIKAMI Yuzuru的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The genetic diversity of recent clinical isolates of Candida albicans in Japan and Thailand was studied on the basis of amplified DNA band lengths determined with a specific PCR Primer. Our analyses of 401 clinical isolates of C.albicans showed that they could be classified into five genotypes A, B, C, D (C.dubliniensis) and a new genotype E. Most of the strains from Japan as well as Thailand were genotype A, and C was a minor group. The genotype E was characterized to have a group 1 intron-like sequence, which is longer that hitherto reported ones ad which has a nucleotide sequence length of 962-bp. Our analysis of the 962-bp sequence indicated that it is composed of an intron similar to that of C.dubliniensis of 621-bp with a 341-bp insertion. Analysis of the sequence of ITS region of the E showed that the sequence is identical with those of C.albicans. Throught the study, the possible horizontal transfer of the group 1 intron between C.dubliniensis and C.albicans E was suggested. A high degree of correlation between the presence of group l intron in genotype E and the susceptibility to flucytosine was observed. Five and two strains of C.dubliniensis from Japan and Thailand, respectively. They were not isolates from AIDS patients, and not resistant to azole-type antifungals such as fluconazole. Most of the resistant strains were found to belong to genotype A, B, o r, C, in Japan and Thailand. Detailed mechanisms of resistant of C.albicans (not C.dubliniensis) to azole and flucytosine ant ifungals were analyzed using micro-array method using home made array system in our laboratory.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
Myoken Y, Mikami Y et al.: "A tropical antifungal medication in immunocompromised patients"Oral Surgery Oral Medicine Oral Pathol. 381-380 (2004)
Myoken Y、Mikami Y 等人:“免疫功能低下患者的热带抗真菌药物”口腔外科口腔医学口腔病理。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Melkusova S, Mikami Y et al.: "The efficiency of benzothiazole ABP, echinocandin, micafungin, and amphotericin B ma fiuconazle -resistant Candida albicans and Candida dubliniensis"Pharmzie. (in press). (2004)
Melkusova S、Mikami Y 等人:“苯并噻唑 ABP、棘白菌素、米卡芬净和两性霉素 B 对氟康唑耐药的白色念珠菌和都柏林念珠菌的功效”Pharmzie。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Myoken Y, Mikamu Y et al.: "Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia"J.Oral.Pathol.Med.. 32. 1496-1497 (2003)
Myoken Y、Mikamu Y 等人:“在患有急性白血病的中性粒细胞减少症患者中由唑类耐药白色念珠菌引起的突破性真菌血症”J.Oral.Pathol.Med.. 32. 1496-1497 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katsu M, Mikami Y, et al.: "Immunomangnetic isolation of Cryptococcus neoformans by beads coated with anti-Cryptococcus serum"Jpn.J.Med.Mycol.. 44. 139-144 (2003)
Katsu M, Mikami Y, et al.:“通过涂有抗隐球菌血清的珠子对新型隐球菌进行免疫磁性分离”Jpn.J.Med.Mycol.. 44. 139-144 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    A novel identification method of pathogenic Nocardia based on whole genome information
    • 批准号:
      19590441
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2007
    • 负责人:
      MIKAMI Yuzuru
    • 依托单位:
    Development of new classification system for pathogenic Nocardia based on whole genome sequences and microarray analysis
    • 批准号:
      17590385
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2005
    • 负责人:
      MIKAMI Yuzuru
    • 依托单位:
    Rapid molecular identification of imported mycoses in Japan
    • 批准号:
      11670259
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.73万
    • 财政年份:
      1999
    • 负责人:
      MIKAMI Yuzuru
    • 依托单位:
    Analyzes of a new rifampicin resistant mechanism by acid-fast bacteria
    • 批准号:
      08670301
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1996
    • 负责人:
      MIKAMI Yuzuru
    • 依托单位: